Trial
NCT01710228
Alternative Treatment Paradigm for Natalizumab Trial
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Teva Branded Pharmaceutical Products R&D, Inc.; The University of Texas Health Science Center, Houston; University of Alabama at Birmingham; Charite University, Berlin, Germany
Condition
Multiple Sclerosis (MS)
Intervention
methylprednisolone
Why stopped
sponsor stopped
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-29